pergolide has been researched along with Dyskinesia, Drug-Induced in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H | 1 |
| Bonnet, AM; Houeto, JL | 1 |
| Cannizzaro, C; Jackson, MJ; Jenner, P; Maratos, EC; Pearce, RK | 1 |
| Braus, DF; Büchel, C; Diehl, A; Gattaz, WF; Krumm, B; Medori, R | 1 |
| Gerlach, M; Reichmann, H; Riederer, P | 1 |
| Cannas, A; Floris, G; Solla, P; Tacconi, P | 1 |
| Burger, E; Härtter, S; Kvernmo, T | 1 |
| Clemens, JA; Fuller, RW; Hynes, MD | 1 |
| Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I | 1 |
| Facca, A; Sanchez-Ramos, J | 1 |
| Clarke C, E; Speller J, M | 2 |
| Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L | 1 |
| Forster, C; Herrera-Marschitz, M; Ungerstedt, U | 1 |
| Gopinathan, G; Lieberman, AN; Neophytides, A | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
3 review(s) available for pergolide and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
Topics: Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Ergolines; Heart Valve Diseases; Humans; Indoles; Pergolide; Pulmonary Fibrosis; Receptors, Dopamine | 2006 |
Pergolide for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide | 2000 |
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide | 2000 |
4 trial(s) available for pergolide and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |
[Pergolide: a useful agonist for the treatment of Parkinson disease].
Topics: Antiparkinson Agents; Disease Progression; Dopamine Agonists; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 2002 |
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1995 |
Switching from pergolide to pramipexole in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome | 2001 |
9 other study(ies) available for pergolide and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Motor Activity; Parkinsonian Disorders; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Severity of Illness Index | 2003 |
[Tardive dyskinesia: pergolid, a possible therapeutic option].
Topics: Adult; Aged; Antipsychotic Agents; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neurologic Examination; Neuroprotective Agents; Pergolide; Pilot Projects; Schizophrenia; Treatment Outcome | 2003 |
Levodopa in the treatment of Parkinson's disease: current controversies.
Topics: Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Lisuride; Parkinson Disease; Pergolide | 2005 |
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation.
Topics: Antiparkinson Agents; Benserazide; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Homeostasis; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Paraphilic Disorders; Parkinson Disease; Pedophilia; Pergolide | 2006 |
Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corticosterone; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Ergolines; Homovanillic Acid; Male; Motor Activity; Pergolide; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; Synapses | 1982 |
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide | 1996 |
Neuroleptic drugs and their action on different neuronal pathways.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Ergolines; gamma-Aminobutyric Acid; Humans; Motor Activity; Neural Pathways; Pergolide; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission | 1985 |
Efficacy of pergolide and mesulergine.
Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1986 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |